The cholecystokinin (CCK)-Blgastrin receptor binds two brain-gut hormones, CCK and gastrin, with high affinities. These peptides have a trophic effect on gastrointestinal cells expressing the receptor in vivo as well as in vitro. Recently, this receptor mRNA was reported t o be expressed in immunocytes localized in the lamina propria of normal rat stomach mucosa. Here, we studied the receptor expression in human hematopoietic cells in order t o determine whether they play a role in cell growth. The CCK-B/gastrin receptor mRNA was detectable in the polymorphonuclear (PMN) cells but not in the mononuclear cells of normal peripheral white blood cells by reverse transcription-polymerase chain reaction. The receptor transcript was, however, expressed in human leukemia cell lines (14 of 18 cell lines tested) derived
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from not only myeloid, but also T-and B-lymphoid lineages. The CCK-B/gastrin receptors on several leukemia cell lines were shown t o be biologically active by demonstrating ligand-dependent cell proliferation in serum-deprived medium. Interestingly, a human CCK-Blgastrin receptor specific antagonist, YM022, but not its stereotype isoform, selectively inhibited the DNA synthesis of THP-1, MOLT-16, MOLT-14, and CCRF-CEM in the absence of exogenous peptide ligands. Further investigation revealed that these leukemia cell lines and normal PMN cells also expressed gastrin mRNA. These results suggest that growth of human leukemia cells is promoted by an autocrine mechanism through the CCK-Blgastrin receptors.
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designated YM022, and an enantiomer of YM022, YM022-S, were kindly provided by Yamanouchi Pharmaceutical Co, Ltd (Tsukuha, Japan). YM022-S is about three orders of magnitude less potent in the competitive binding for '251-laheled CCK-8 or gastrin I than YM022."
Peripheral blood was obtained from five healthy volunteers and collected in heparinized tubes. Polymorphonuclear cells (PMN) were separated by gradient sedimentation over Mono-Poly Resolving Medium (ICN Biomedicals Inc, Aurora, OH). The cells were pelleted to 1.5 X 10' cells per donor. Mononuclear cells (MNC) were separated by gradient sedimentation over Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden). The cells were washed once by calcium and magnesium-free phosphate-buffered saline (PBS), resuspended in RPMI 1640 medium (GIBCO, Grand Island, NY), disseminated over 2684 IWATA ET AL maintained in suspension culture using RPMI 1610 medium supplemented with 10% fetal calf serum (ICN Flow, Costa Mesa, CA) and antibiotics in a 95% air, 5% COz atmosphere at 37°C.
Total cellular RNA was extracted from normal human white blood cells (PMN, adherent and nonadherent MNC) and leukemia cell lines by using an acid guanidinium thiocyanate-phenol-chloroform method as described.'x The cDNA templates for PCR analyses were prepared by RT of total RNA (2 fig) S'-TGCAGCGACTATGTGTGTATGTGCTGATCT-3'; antisense primer, S'-GGCCGAAGTCCATCCATCCATAGGCTTC-3': p-actin: sense primer, 5'-ACCACACCTTCTACAATGAGCTGCGTG-3'; antisense primer, 5'-CACAGCTTCTCCTTAATGTCACGC-ACG-3') and 1.25 units of Taq DNA polymerase (Promega, Madison, WI).*."'." These primer pairs are designed to amplify genomic fragments including one or two introns. Thus, the size of fragments amplified from the contaminating genomic DNA is different from that of the cDNA bands. The reaction conditions were as follows: denaturation at 94°C for 30 seconds, annealing at 72°C for 1 minute and extension at 72°C for I minute. The reaction was performed for 35 cycles in a GeneAmp PCR system 9600 (PerkinElmer Cetus, Norwalk. CT)?
Southern hlor analysis. To confirm amplification of the appropriate DNA fragments, the RT-PCR products (8 ,uL of a 25 ,uL reaction mixture) were electrophoresed in a I % agarose gel and transferred onto nitrocellulose filters. The filters were hybridized at 42°C in a buffer containing 50% (wt/vol) formamide and full-length "P-labeled cDNA probes. After a 16-hour hybridization, the filters were washed twice for 15 minutes in 2 X SSC ( I X SSC is 0.15 molL NaCI-0.015 molL sodium citrate, pH 7.0). 0.1% sodium dodecyl sulfate (SDS) at room temperature, and twice for 30 minutes in 0.1 X SSC, 0.1 % SDS at W C , and then subjected to autoradiography." The DNA synthesis of the HL-60, U-937, THP-I, Hair-M, Jurkat, HPB-MLT, MOLT-16, MOLT-3, HPB-ALL, MOLT-14, and CCRF-CEM cell lines were measured by [methyl-'Hlthymidine incorporation. Cells (2 X IO5 cells per well) were preincubated in serum-deprived medium for 24 hours, and then cultured in 96-well plates in the presence or absence of various concentrations of peptide ligands with or without receptor antagonists for 44 hours, followed by a further 4-hour incubation with [methy/-'H]thymidine ( I mCilmL, 25 mcilmmol: Amersham International plc, Buckinghamshire, UK). The radioactivity of incorporated [methyL3H]thymidine in 5% trichloroacetic acid-insoluble precipitates was counted by using a scintillation counter (Top Count. Packard, Meriden, CT).
Cells were grown to confluence over a 4-day period in 9 cm diameter petridishes. Fresh growth medium was then added. After 48 hours, culture supernatants were collected and assayed for immunoreactive gastrin levels using a radioimmunoassay kit (Dainabot, Inc, Tokyo, Japan).
The statistical significance of the difference between antagonist-treated and control cell DNA synthesis was assessed by analysis of variance followed by Student's t-test (P < .01). examine the expression of CCK-B/gastrin receptor mRNA in normal human peripheral white blood cells, RT-PCR was performed using specific paired primers in the presence or absence of RT (Fig I) . A 528-bp sequence was amplified from CCK-B/gastrin receptor mRNA. Southern blot analysis of RT-PCR products showed the expression of this receptor mRNA only in PMN among normal peripheral white blood cell fractions. No signal was detected in reactions without RT, indicating that the observed signals were due specifically to the presence of receptor transcripts. Contaminating genomic DNA did not confound the analysis, because the primers amplified the 922-bp fragment from the genomic IOCUS.~~'~ Primers specific for human &actin generated the expected 365-bp specific band and confirmed the presence of intact mRNAs in all samples (Fig 1) . The results were reproducible in all RNA samples extracted from five individuals.
RESULTS
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Expression of CCK-B/gastrin receptor mRNA in various human leukemia cell line lineages. To elucidate the lineage specificity, we next examined the expression of the CCK-B/ gastrin receptor transcript in various human leukemia cell lines by RT-PCR followed by Southern blot analysis. Surprisingly, it became clear that the CCK-B/gastrin receptor was expressed in all sorts of leukemia lineages in widely varying amounts (HL-60, THP-I , ML-I , MOLM-1 in myeloid, NALM-6, NALM-26, Daudi, Hair-M in B lymphoid and Jurkat, MOLT-16, MOLT-3, MOLT-14, CCRF-CEM, RPMI-8402 in T lymphoid cells) (Fig 2) . No signal was detected in reactions without RT. Expression was undetectable in U-937, HPB-MLT, HPB-ALL, and DND-41.
We have tried to quantify the expression levels of CCK- -
B/gastrin receptor mRNA in these leukemia cell lines by RNA blot analysis.' However, most of them except for Jurkat and MOLT-I4 were under the detectable level by the analysis (data not shown).
Inhibition of leukemia cell growth by a specific antagonist for human CCK-B/gastrin receptors. We previously showed that the peptide ligands, CCK-8 and gastrin I could promote DNA synthesis and cell growth of Chinese hamster ovary or mouse NIH 3T3 fibroblast cells transfected with a human CCK-B/gastrin receptor cDNA expression vector.s.h.X Thus, we next examined the effect of CCK-8 on DNA synthesis of 11 human leukemia cell lines (Table I) (Table I ). The receptor mRNA was expressed on Hair-M and MOLT-16, but exogenous CCK-8 (IO-' mol/L) did not stimulate their DNA synthesis.
DNA synthesis of MOLT-14 was stimulated by CCK-8 in a dose-dependent manner. It was completely blocked by a specific CCK-B/gastrin receptor antagonist, YM022, but not by its stereoisomer, YM022-S (Fig 3) . Gastrin I similarly promoted DNA synthesis (data not shown). These results indicate that the CCK-B/gastrin receptors expressed on MOLT-14 are biologically functional.
Even in the absence of exogenous CCK-8, DNA synthesis of MOLT-I4 was inhibited by YM022, but not by YM022-S (Fig 3 legend) . Thus, we further examined the effect of YM022 on DNA synthesis of several leukemia cell lines. Surprisingly, YM022, but not YM022-S, selectively inhibited not only DNA synthesis of MOLT-I4 but also that of THP-I, MOLT-I6 and CCRF-CEM cells in the absence of exogenous peptide ligands ( Table 2 ). The inhibitory effect of YM022 for DNA synthesis of MOLT-I4 in serum-deprived medium was concentration-dependent (Fig 4) . No obvious effect of YM022 or YM022-S was seen in Hair-M or HPB-ALL cells. This implies that YM022 inhibited proliferation of THP-I, MOLT-16, MOLT-I4 and CCRF-CEM cells by specific interaction with the CCK-B/gastrin receptor. These results raise the possibility that leukemia cell growth is promoted by an autocrine mechanism through CCK-B/gastrin receptors.
Coexpression of gastrin and its receptor mRNAs in several human leukemia cell lines. To support the presence of an autocrine mechanism, we examined the expression of the gastrin gene in human leukemia cell lines. By RT-PCR using a specific pair of primers for the human gastrin gene, a 279-bp sequence was amplified from gastrin mRNA. The contaminating genomic DNA did not interfere with the analysis. The primers amplify a 409-bp fragment from the genomic IOCUS.~" Southern blot analysis revealed that this ligand mRNA was expressed in almost all human leukemia cell lines (17 of 18 cell lines) tested (Fig 5) . Both gastrin and its mRNA (U-937, HPB-MLT, HPB-ALL, and DND-41). Among normal human peripheral white blood cells, only PMN expressed gastrin mRNA (Fig 6) . No signal was detected in reactions without RT.
The mRNA expression of the gastrin gene in the leukemia cell lines was also under the detectable levels by Northern blot analysis as that of the CCK-B/gastrin receptor gene (data not shown). However, we could detect gastrin-like immunoreactivity in the conditioned media of several leukemia cell lines. Jurkat, HPB-ALL and MOLT-14 produced 20, 26, and 27 pg gastrin per 10" cells over a 48-hour period, respectively.
DISCUSSION
In the last two decades, experimental evidence has suggested that neuropeptides play important roles in the modulation of the immune system through receptor-mediated events. For example, sensory neuropeptides such as somatostatin, vasoactive intestinal peptide and substance P have been reported to modulate T lymphocyte function.'*," The CCK-A (peripheral type CCK) receptor has been reported to mediate inhibition of cell growth in MOLT-4 lymphoblasts." Receptors for substance P, opiate peptides and benzodiazepine have been shown to be involved in chemotaxis of human monocytes.'4.2'-26 In addition, substance P has been shown to stimulate hematopoiesis for both erythroid and granulocytic progenitors in short-term bone marrow ~u1tures.l~ Furthermore, the receptor transcript of nerve growth factor, trk, is functionally expressed in human immune and hematopoietic cells.*'-'" On the other hand, erythropoietin receptors have been shown in the central nervous system3' Many receptors for peptide hormones, growth factors and cytokines previously thought to be limited to the brain or the immunohematopoietic system are now known to be expressed by both."
The CCK-B receptor that binds CCK-8 as well as gastrin I with high affinities, has been pharmacologically shown to be expressed on a human Jurkat T lymphocyte cell line." But, its biological function is unknown. Recently, Mezey et all" reported that immune cells in the lamina propria are the only cells that express detectable mRNA for gastrin receptors in the rat gastric mucosa by in situ hybridization histochemistry. Our present study revealed that the CCK-B/gastrin receptor mRNA was expressed in normal human PMN cells and in both the myeloid and lymphoid lineages of leukemia cell lines. These results give rise to the importance of further elucidation of the physiological interaction between the neuroendocrine and immuno-hematopoietic systems. CCK-B/gastrin receptor mRNA is not detectable in nonadherent normal MNC but is in several tumor cell lines including T-and B-lymphoid lineages. It is of interest to determine whether the leukemia cells ectopically express the peptide hormone receptor. If so, the receptor could be a novel molecular probe for the diagnosis of neoplasms derived from the immuno-hematopoietic system as well as that of human small cell lung cancers.' It would be important to examine the expression in the progenitor cells of the human bone marrow, lymph node, or thymus.
In the present study, we also showed for the first time that the CCK-B/gastrin receptor mediates cell proliferation of several human leukemia cells in a ligand dependent manner. Moreover, YM022 but not its stereoisomer specifically inhibits the proliferation of THP-1, MOLT-16, MOLT-14, and CCRF-CEM cells in serum-deprived medium. The transcripts of a peptide ligand, gastrin, and its receptor genes are coexpressed in these leukemia cell lines. The expression level of gastrin mRNA in the leukemia cell lines was too low to be detected by RNA blot analysis. However, the presence of gastrin-like immunoreactivity was confirmed in the conditioned media of several leukemia cells. These results are consistent with previous reports of a human colon carcinoma cell line, HCT 1 16.33.34 Thus, our present results imply that leukemia cell growth is accelerated by an autocrine mechanism through the CCK-B/gastrin receptor. Data suggesting that gastrin could participate in an autocrine loop driving tumor cell growth have been reported for other human neoplastic cell lines derived from the colon, stomach, and kidne~.'~.~' Our current data are the first to suggest the presence of a gastrin autocrine system in human neoplastic cells derived from nonepithelial (mesoderm) origin.
Very recently, posttranslational processing intermediates of gastrin, specifically glycine-extended gastrin, as well as gastrin itself have been reported to stimulate the proliferation of a rat pancreatic tumor cell line and mouse Swiss 3T3 fibroblast^.^^,^^ Glycine-extended gastrin was at least four orders of magnitude less potent than gastrin in its ability to induce acid secretion. Moreover, CCK-B/gastrin receptorselective antagonists did not inhibit the proliferation induced by glycine-extended gastrin. This implies that there could be two gastrin receptors that mediate the proliferative action of peptides derived from the gastrin gene. Although immunoreactive gastrin was detected in the conditioned media of leukemia cell lines, we could not distinguish between amidated gastrin and glycine-extended form by the assay. This may help to explain the varying inhibitory effects of a CCK- of hematopoietic tumor cell lines. Moreover, in certain leukemia cell lines such as THP-1, MOLT-16, MOLT-14, and CCRF-CEM, an autocrine mechanism seems to promote cell growth. To elucidate the physiological and pathological significance of the CCK-B/gastrin receptor in immuno-hematopoietic systems, further studies are necessary.
